Valeant Pharma (VRX) says ex-CEO Pearson is still consulting in 'limited' capacity - Conf. call
Tweet
Share
E-mail
Valeant Pharma (NYSE: VRX) says ex-CEO Mike Pearson is still consulting in 'limited' capacity, according to the company's conference call on Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Solaris Energy Infrastructure to Join S&P SmallCap 600
- Buy this aerospace stock on attractive valuation: BofA
- William Blair says buy the dip in this Industrial stock
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
